Dr. Ruffner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3213 W Wheeler St
#427
Seattle, WA 98199Phone+1 949-637-0256- Is this information wrong?
Education & Training
- Fred Hutchinson Cancer Research Center1998 - 2001
- University of Michigan Health SystemResidency, Internal Medicine, 1995 - 1998
- University of Tennessee Health Science Center College of MedicineClass of 1995
Certifications & Licensure
- TN State Medical License 2001 - 2015
- CA State Medical License 2008 - 2012
Clinical Trials
- US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) Start of enrollment: 2019 Dec 09
Publications & Presentations
PubMed
- 83 citationsIncidence and Outcome of Chronic Graft-versus-Host Disease Using National Institutes of Health Consensus CriteriaMadan Jagasia, Jennifer L. Giglia, Wichai Chinratanalab, S. Dixon, Heidi Chen, Haydar Frangoul, Brian G. Engelhardt, Stacey Goodman, John P. Greer, Adetola A. Kassim, ...> ;Biology of Blood and Marrow Transplantation. 2007 Oct 1
- 7 citationsHigh-dose chemotherapy followed by autologous stem cell transplantation for relapsed or refractory Hodgkin lymphoma: prognostic features and outcomes.Brian G. Engelhardt, Derek W Holland, Stephen J. Brandt, Wichai Chinratanalab, Stacey Goodman, John P. Greer, Madan Jagasia, Adetola A. Kassim, David S. Morgan, Kather...> ;Leukemia & Lymphoma. 2007 Sep 1
- 104 citations131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remiss...John M. Pagel, Frederick R. Appelbaum, Janet F. Eary, Joseph G. Rajendran, Darrell R. Fisher, Ted Gooley, Katherine Ruffner, Eneida R. Nemecek, Eileen Sickle, Larry Du...> ;Blood. 2006 Mar 1
- Join now to see all
Press Mentions
- Cardiff Oncology : Announces Departure of Chief Medical Officer - Form 8-KApril 12th, 2022
- Cardiff Oncology Announces Departure of Chief Medical OfficerApril 12th, 2022
- Cardiff Oncology Announces the Appointments of Katherine L. Ruffner, M.D., as Chief Medical Officer and James E. Levine as Chief Financial OfficerJuly 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: